Gennao Bio

0 followers


Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Industries

Employees

11-50

Links


Org chart

Chris Duke
Interim CEO
Collapse
Dale L. Ludwig
Chief Scientific Officer
Bruce T.
Board Member, Founder, and Chief Scientific Advisor
John Heyburn
Senior Vice President, Program Management

Board & advisors